Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.99
+0.30 (1.22%)
May 7, 2026, 4:00 PM EDT - Market closed
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.51 billion as of May 8, 2026. Its market cap has increased by 41,340.47% in one year.
Market Cap
1.51B
Enterprise Value
1.25B
1-Year Change
41,340.47%
Ranking
Category
Stock Price
$24.99
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.51B, an increase of 308.64%. That is a compound annual growth rate of 29.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 1.51B | 4,000.13% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.60B |
| Immunocore Holdings | 1.57B |
| Precigen | 1.56B |
| Immatics | 1.55B |
| Bicara Therapeutics | 1.54B |
| AtaiBeckley | 1.53B |
| Novavax | 1.53B |
| Biohaven | 1.51B |